AHK-Cu
Coming soonCopper tripeptide AHKCopper(II) complex of the tripeptide Ala-His-Lys. Published work on AHK-Cu itself is limited to one ex vivo hair follicle study and related cell-culture work, so researchers also read the wider copper-peptide literature.
Supplied as a single-chamber lyophilized vial with a colour-coded cap (Anti-Aging).
Research literature, not dosing or treatment instructions.
- AHK-Cu was examined on human hair follicles ex vivo and on cultured dermal papilla cells. (PMID 17703734)
- A vitamin C-linked conjugate of the AHK tripeptide, without copper, was examined on osteoblast differentiation in a cell culture model. (PMID 29567599)
Add the solvent slowly along the vial wall; swirl gently, never shake. Allow to dissolve fully. Six-step guide with photos →
Concentration calculator only. Enter the mass being calculated; blend components are not added automatically. Products are for in-vitro research.
Refer to the product label and supplier documentation for storage conditions. Lot-specific storage and expiry information is not available here.
Each certificate is published with its lot number.
Questions about AHK-Cu
How much published research is there on AHK-Cu?
The research library's PubMed search for AHK-Cu returned 31 records on 5 October 2026, 0 of them reviews. The library lists 2 studies chosen for what they measured. ClinicalTrials.gov lists no registered study naming AHK-Cu (checked 5 October 2026).
Is AHK-Cu an approved medicine?
No medicinal product containing AHK-Cu is listed in Drugs@FDA (checked 5 October 2026), and the research material we supply is not a medicine. It is supplied for in-vitro laboratory research only, not for human or veterinary use.
Why are the formula and weight those of the copper-free peptide?
PubChem has no compound record under CAS number 88478-30-8, so the number could not be confirmed there. The formula and weight shown are those of the copper-free peptide AHK (PubChem CID 7408502); the supplied material is the copper(II) complex.
How does AHK-Cu differ from GHK-Cu?
GHK-Cu and AHK-Cu are copper(II) complexes of two tripeptides that differ only at the first residue, glycine in GHK and alanine in AHK. GHK-Cu has a large literature; AHK-Cu has a small one.
How is the identity of AHK-Cu confirmed on a certificate?
A research-grade certificate of analysis typically reports identity by mass spectrometry and purity by HPLC. The mass result is read against the average molecular weight of 354.41 Da listed on this page. The research library's guide to reading a certificate explains each field.
What other names is AHK-Cu published under?
AHK-Cu is also written Copper tripeptide AHK and AHK Cu. The catalog lists it under the name AHK-Cu.
Is this product for human use?
No. Peptency products are supplied for in-vitro research only. Not for human or veterinary use, not for diagnosis or therapy.
Where can I find shipping information?
Current shipping rates and delivery information are on the Shipping & payment page, and the rates that apply to your order are shown at checkout.
Often studied with
For research use only. Not for human or veterinary use.
What is AHK-Cu?
AHK-Cu is the copper(II) complex of the tripeptide L-alanyl-L-histidyl-L-lysine. Its own literature is small: one ex vivo study on human hair follicles and cultured dermal papilla cells, and cell-culture work on a vitamin C-linked AHK conjugate. We supply AHK-Cu as a lyophilized vial for in-vitro laboratory research only.
What are the chemical identifiers of AHK-Cu?
AHK-Cu has the molecular formula C15H26N6O4, an average molecular weight of 354.41 Da and CAS number 88478-30-8.
PubChem has no compound record under CAS number 88478-30-8, so the number could not be confirmed there. The chemistry shown here is the copper-free peptide AHK (PubChem CID 7408502).
Chemistry checked against PubChem (CID 7408502), 5 October 2026; full chemistry record in the research library.
What does published research on AHK-Cu cover?
A PubMed search for AHK-Cu returned 31 records on 5 October 2026, 0 of them reviews. Our research library lists 2 of these studies, chosen for what they measured.
- AHK-Cu was examined on human hair follicles ex vivo and on cultured dermal papilla cells. (Pyo et al., Arch Pharm Res, 2007; PMID 17703734)
- A vitamin C-linked conjugate of the AHK tripeptide, without copper, was examined on osteoblast differentiation in a cell culture model. (Jung et al., Differentiation, 2018; PMID 29567599)
Mechanism, every cited study and the regulator records are on the AHK-Cu page of the research library. Papers are listed by what they measured, not as evidence of any use.
How is AHK-Cu supplied and stored?
AHK-Cu is supplied as a lyophilized (freeze-dried) powder in a sealed vial, for in-vitro laboratory research only. Our stated storage condition for the sealed lyophilized vial is 2 to 8 °C. The label and the lot certificate carry the lot-specific storage condition and expiry date.
What is the regulatory status of AHK-Cu?
Drugs@FDA lists no application naming AHK-Cu as an active ingredient (checked 5 October 2026).
A regulator record is information about a database entry. It is not advice and not a statement that any use is lawful or unlawful in any country. How regulators approach research peptides.
Which related research pages and compounds are listed?
- AHK-Cu: chemistry, literature and regulatory status
- AHK-Cu compared with GHK-Cu
- Copper-binding tripeptides
- How to read a certificate of analysis
Related compounds in the catalog: